Ganesha (G or G-0), also known as 3,4-dimethyl-2,5-dimethoxyamphetamine or as 3-methyl-DOM, is a psychedelic drug of the phenethylamine, amphetamine, and DOx families. It is the 3-methyl derivative of DOM and the amphetamine (ñ-methyl) derivative of 2C-G. The drug is taken orally.
In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists Ganesha's dose range as 24 to 32mg orally and its duration as 18 to 24hours. The drug's onset was variably described as slow over the course of 3hours or as rapid. The effects of Ganesha have been reported to include strong closed-eye visuals, an increased appreciation of music, and powerful relaxation and tranquility, among others. Shulgin named Ganesha after the Hindu deity, Ganesha. It is one of his "ten classic ladies", a series of methylated DOM derivatives.
The chemical synthesis of Ganesha has been described.
Homologues of Ganesha (G-0) include G-3, G-4, G-5, and G-N, among others.
Ganesha was first described in the literature by Alexander Shulgin in his book PiHKAL (Phenethylamines I Have Known and Loved) in 1991.
Ganesha is a controlled substance in Canada under phenethylamine blanket-ban language.
This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.
Ganesha is not an explicitly controlled substance in the United States. However, it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption. In addition, the drug may considered a controlled substance as a positional isomer of DOET.